Practical Licensing 18 - 21 May 2020

User login

You need to log in to register for events

Is this course right for me?

The course is designed for people with some experience of licensing, e.g. they have run a few smaller deals themselves or have been involved indirectly in a larger licensing deal. Delegates will probably have been working in a tech transfer role for somewhere between 12 months and 3 years. 

Those with experience of research contracts, even without direct commercial licensing experience, will also find this beneficial – although the focus of the course will be on a stand-alone licensing deals, licensing issues will often need to be addressed as part of a research contract negotiation.

The course is viewed from the perspective of universities licensing their technology to industry (which may include to a spin-out company), but it’s equally valuable for those working in industry who are dealing on the other side of the fence as it will enable them to understand the unique pressures that a university is under when licensing its technology. 

It may also be useful to those working in funding bodies, particularly those that require or expect the universities to undertake some form of commercial exploitation of the work to better understand the complexities and difficulties of striking a licensing deal.

This is a natural follow on course to Fundamentals of Technology Transfer; indeed, many of the topics introduced there are developed further in this course.

Delegates are not expected to have any legal training, but a basic understanding of IP will be beneficial.


Why should I attend this course?

  • Licensing is a common route for knowledge exchange, but the complexities can make this a slow and painful process. 
  • Licensing early stage technology is often difficult. Universities in particular face unique challenges on the terms they can accept when licensing their IP that industry is not always aware of.
  • This course will give the delegates the tools they need to better structure their licence deals and give them the confidence to negotiate the key terms.
  • Licensing is not just relevant for the ‘big ticket’ tech transfer deals; licence terms are often included in research funding agreements, collaboration agreements, etc.


What will I learn from the course?

  • Learn how to formulate a licensing strategy (which will include a financial strategy)
  • Understand the key issues in a licence agreement and how the principles inter-relate
  • Gain confidence for negotiating the terms of a licence agreement
  • Understand and be able to assess the risks of ‘less than favourable’ terms.
  • Explore both successful and unsuccessful licensing case studies and identify what worked and what could have been improved.
  • Learn how to manage the licensing relationship post-signature.

The course also focuses on networking, providing a valuable platform to meet peers, discuss best practice, and interact with the course team and other contributors.


PLEASE NOTE: There may be a requirement for delegates to undertake some pre-course work/reading before the course begins.


What makes this course different to others available in the sector?

PraxisAuril is able to deliver this training from the unique perspective of KE practitioners. We see the world from the same angle as you do!

We draw on a wide pool of experience and expertise from within the profession and build them into the course content, ensuring we are always delivering up to date, sector leading training and development.

View outline programme (subject to change)

The course fee includes:

  • Attendance at all lectures and workshops
  • Training and reference materials (electronic or otherwise)
  • Registration event (including buffet dinner & drinks) on Monday 18 May 2020
  • Networking event (including buffet dinner & drinks) on Tuesday 19 May 2020
  • Morning and afternoon refreshments and lunch every day



The course will be held at Burleigh Court which is located on the Loughborough University campus (West Entrance). Loughborough railway station is three miles away - taxis are available at the station or there is a regular shuttle bus every 20 minutes from the station to the venue. If you are driving, Burleigh Court is one mile from junction 23 on the M1; ample free secure on-site car parking is available. Nottingham East Midlands Airport is just eight miles away.


Discounted bed and breakfast accommodation is available at Burleigh Court at £95.00 per night, per person. Please book your accommodation direct with Burleigh Court by calling 01509 633030 and quote the PraxisAuril event reference number 361748 in order to receive the discounted rate. Discounted rates are not available when booking accommodation online.  Any bedrooms that are not booked by Monday 20 April 2020 will be released. Accommodation may still be available at Burleigh Court after this date but might not be at the discounted rate.

Please note that the course begins with registration, including dinner and drinks, on Monday 2 March from 1830-2030.

14 ATTP Points

18th May - 21st May


Course Fee (Member Price - £1125.00) £ 1495.00

Meet the Speakers/Trainers

Mr. Paul Maclennan

Course Director
Partner / Solicitor, Anderson Law LLP
Paul Maclennan is a solicitor and a Partner at Anderson Law LLP, a niche firm of commercial/IP solicitors based in Oxfordshire. Paul advises on a wide variety of commercial agreements focussing on transactional work within the IT, life sciences and university sectors. His clients include leading UK universities and an international IT/telecoms company. Paul is listed in Chambers & Partners as a leading UK lawyer in the field of Intellectual Property and is a contributor to a number of Anderson Law’s publications on intellectual property and commercial law, most recently Technology Transfer (3rd Ed, Bloomsbury, 2010). Paul can be reached at

Dr. Iain Thomas RTTP

Co-Course Director
Head of Life Sciences, Cambridge Enterprise Ltd
Iain is Head of Cambridge Enterprise’s Life Sciences team at the University of Cambridge where he and his team work in fields as diverse as therapeutics, diagnostics, biofuels, IVF, epigenetics and agritech. CE’s portfolio of products includes alemtuzumab (Sanofi), breast cancer markers (Brevagen) and mouse touch screen chambers (Campden Instruments). Recent spin-outs include Morphogenix, Mission Therapeutics, Cambridge Epigenetix, XO1 Therapeutics (sold to Janssen), Z-factor, Phoremost, and Storm Therapeutics. Iain led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the SBC and was the Cambridge lead for the Apollo Therapeutics Fund. Iain has been an active trainer for Praxis Courses since 2004.
Book now